Figure 4

Kaplan–Meier analyses of overall survival (OS) and remission duration in T-ALL with respect to BCL11b mRNA expression. A: T-ALL patients with low BCL11b expression showed significant inferior OS than patients with higher expression (low expression quartile Q1 vs. high Q2-4 expression quartiles; P = 0.02; log-rank test). B: The BCL11b low expressing thymic T-ALL patients had a highly significant inferior OS (P < 0.01).